window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-ZXTT8H6EZ1');
FacebookX

iThera Medical reports initiation of fifth clinical site in EUPHORIA study for the non-invasive assessment of IBD

By |2022-06-22T08:41:19+01:00June 22nd, 2022|

Medical device company iThera Medical, our coordinator, announces that the fifth site has been initiated for the ongoing clinical study in the EUPHORIA project that aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The EUPHORIA (Enhancing Ultrasound and PHOtoacoustics for [...]

Read More

World IBD Day 2022- the EUPHORIA message

By |2022-05-19T07:00:13+01:00May 18th, 2022|

Our 2022 social media campaign on May 19th, #WorldIBDDay includes the messages above and below. Endoscopy is frequently used to monitor IBD, inflammatory bowel disease but can be uncomfortable and expensive. New research and technologies are needed to develop accurate, non-invasive alternatives. The EU-funded EUPHORIA study is doing just that. In EUPHORIA, hospitals in Germany [...]

Read More

iThera Medical exhibits EUPHORIA research at EMIM 2022

By |2022-03-21T14:36:45+00:00March 21st, 2022|

Last week iThera Medical, EUPHORIA's coordinators, exhibited at the 17th European Molecular Imaging Meeting,  EMIM 2022. Partners at iThera discussed the EUPHORIA clinical study with optoacoustic imaging users working with models and patients with inflammatory bowel disease (IBD). The meeting was hosted in Thessaloniki, Greece from March 15th through 18th. Browse the meeting programme and [...]

Read More

Training on MSOT Acuity Echo is happening in Rome!

By |2021-11-04T16:55:40+00:00November 4th, 2021|

Dr Yi Qiu, Application Specialist at iThera Medical is at the Policlinico Tor Vergata hospital in Rome this week. She is training the EUPHORIA clinical study staff there to use the iThera Acuity Echo system on November 3-5th, 2021. This site, Study site 4 will be initiated soon thereafter and then recruit patients to the [...]

Read More

PRESS RELEASE: iThera Medical reports initiation of second site in ongoing clinical study for the non-invasive assessment of inflammatory bowel disease

By |2021-09-23T14:52:54+01:00September 23rd, 2021|

Medical device company iThera Medical announces that the second site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The €2.3 million [...]

Read More

Second German hospital registers participants in EUPHORIA IBD Study

By |2021-09-17T15:29:03+01:00September 17th, 2021|

The EUPHORIA study The EUPHORIA study is now open at the Universitätsklinikum Jena, Klinik für Innere Medizin IV in Jena, Germany. This is the second clinical study site running the EUPHORIA study in Germany and they are currently recruiting patients to take part. Two patients are already registered and scanned with the MSOT [...]

Read More

iThera Medical showcases MSOT Acuity system at European Molecular Imaging Meeting

By |2021-08-26T10:57:42+01:00August 26th, 2021|

After more than a year of COVID-induced conference cancellations, the iThera Medical team is thrilled to be back amongst their users and imaging scientists at #EMIM2021, the European Molecular Imaging Meeting, hosted this year by the University Medical Center in Göttingen. Neal Burton, Tim Devling and Christian Wiest tend their shiny new booth, refurbished for the occasion! Visit [...]

Read More

CE mark awarded to iThera Medical’s MSOT Acuity Echo – a major project milestone

By |2021-06-10T08:14:14+01:00June 9th, 2021|

"We are very excited about the CE certification of our MSOT Acuity Echo system. The integration of ultrasound imaging is key for clinical users of optoacoustics" said Christian Wiest, CEO and co-founder of iThera Medical. Dr Philipp Bell, Chief Commercial Officer at iThera and Coordinator of EUPHORIA said "Obtaining the CE mark is a major milestone for [...]

Read More

Optoacoustic imaging for inflammatory bowel disease webinar available for viewing

By |2021-03-11T12:34:51+00:00March 11th, 2021|

In case you missed it, the iThera Medical-hosted March webinar 'Optoacoustic imaging in inflammatory bowel disease" featuring Prof Dr med. Maximillian Waldner of the Friedrich-Alexander-Universität Erlangen-Nürnberg can be viewed here:   https://youtu.be/6wdD6E1vGKQ  

Read More
EUPHORIA logo

EUPHORIA H2020

EU flagThis project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 830965. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.

Your privacy

We use cookies to improve your experience on this website. We never show advertisements, but do share content from third-parties (e.g. videos). Data about your interaction with the site is used to improve the content that we share.

You can change your mind at any time by updating your settings. Please let us know if you agree.
Cookie Settings Accept

Tracking Cookies

We use Google Analytics to help us improve our website by collecting information on how you use this site. The cookies collect information without directly identifying you. You can read more about our use of Google Analytics on our Privacy Policy.

Third Party Embeds

Pages on this site may include embedded content (e.g. YouTube videos). Embedded content behaves in the same way as if a user had visited that site and these websites may collect data about you. To learn more please visit our Privacy Policy.

Necessary

Necessary cookies help make a website usable by enabling basic functions. The website cannot function properly without these cookies. You may disable these by changing your browser settings but this will affect how the website functions.

Our Privacy Policy

We respect your privacy. Our site uses several third-party services. Please select which cookies you would like to allow by selecting the checkboxes. To learn more or update your settings please visit our Privacy Policy. Thank you.
Go to Top